Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005

2015161 citationsJournal Articlegreen Open Access

Authors

Long-term administration of mifepristone was well tolerated but had no impact on patients with unresectable meningioma.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 33, Issue 34, pp. 4093-4098

Field-Weighted Citation Impact: 9.60